These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
70 related items for PubMed ID: 1383660
1. Safety of anti-HCV-reactive immunoglobulin in heart transplant patients. Donegani E, di Summa M, Bobbio M, Ghisetti V, Marchiaro G, Rizzetto M, Bonino F. Lancet; 1992 Oct 24; 340(8826):1039. PubMed ID: 1383660 [No Abstract] [Full Text] [Related]
3. Do antibodies to the hepatitis G virus E2 antigen in immunoglobulin products reduce infectivity? Cristiano K, Bisso G, Wirz M, Gentili G. Transfusion; 1999 Oct 24; 39(11-12):1271-2. PubMed ID: 10604257 [No Abstract] [Full Text] [Related]
7. Prophylactic use of anti-CMV immunoglobulins in heart transplant recipients: a study on its safety. Metselaar HJ, Velzing J, Rothbarth PH, Balk AH, Mochtar B, Weimar W. Transplant Proc; 1989 Feb 21; 21(1 Pt 3):2504-5. PubMed ID: 2539677 [No Abstract] [Full Text] [Related]
10. Anti-hepatitis A antibody titers after passive immunization with hepatitis A hyperimmune globulin. Poovorawan Y, Theamboonlers A, Vimolkej L, Cryz SJ. Southeast Asian J Trop Med Public Health; 1995 Mar 21; 26(1):193-4. PubMed ID: 8525412 [No Abstract] [Full Text] [Related]
12. Clinical implications of the presence of hepatitis C virus antibodies after kidney transplantation: results of a study using second-generation assays for anti-HCV. Tomikawa S, Uchida H, Nagao T, Beck Y, Degawa H, Watanabe K, Nishimura Y, Nomura Y, Ichikawa N, Kikuchi K. Transplant Proc; 1994 Aug 21; 26(4):2023-5. PubMed ID: 7520619 [No Abstract] [Full Text] [Related]
13. Cytomegalovirus seronegative heart transplant recipients. Prophylactic use of anti-CMV immunoglobulin. Metselaar HJ, Balk AH, Mochtar B, Rothbarth PH, Weimar W. Chest; 1990 Feb 21; 97(2):396-9. PubMed ID: 2153508 [Abstract] [Full Text] [Related]
14. Will sialylation change intravenous immunoglobulin therapy in the future? Käsermann F, Campbell IK. Clin Exp Immunol; 2014 Dec 21; 178 Suppl 1(Suppl 1):100-2. PubMed ID: 25546779 [No Abstract] [Full Text] [Related]
15. IgM and IgG antibodies to hepatitis C virus in patients with mixed cryoglobulinaemia. L'Abbate A, Cutrupi S, Rognetta M, Fabiano C, Craxi A. Clin Exp Immunol; 1993 Nov 21; 94(2):313-6. PubMed ID: 7693384 [Abstract] [Full Text] [Related]
16. Risk of liver disease in HCV-seropositive kidney transplant recipients. Rohr MS, Lesniewski RR, Rubin CA, Johnson RG, Heise ER, McDonald JC, Adams PL. Ann Surg; 1993 May 21; 217(5):512-6; discussion 516-7. PubMed ID: 8387764 [Abstract] [Full Text] [Related]
17. [Detection of anti-HAV, anti-HBV, anti-HCV and anti-HEV antibodies in the patients with sporadic acute hepatitis in Beijing during 1995-2000]. Jiang Y, Lu J, Zhao H. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Dec 21; 15(4):360-2. PubMed ID: 11986727 [Abstract] [Full Text] [Related]
18. Effect of immune globulin on the prevention of experimental hepatitis C virus infection. Krawczynski K, Alter MJ, Tankersley DL, Beach M, Robertson BH, Lambert S, Kuo G, Spelbring JE, Meeks E, Sinha S, Carson DA. J Infect Dis; 1996 Apr 21; 173(4):822-8. PubMed ID: 8603959 [Abstract] [Full Text] [Related]
19. Prevalence of anti-HCV positivity in hemodialysis and renal transplant patients at our center. Bilgin N, Simşek H, Haberal M. Transplant Proc; 1993 Dec 21; 25(6):3261-2. PubMed ID: 7505501 [No Abstract] [Full Text] [Related]
20. [Outcome of HCV infection in intravenous drug addicts and influential factors]. Huang HL, Ye SR, Leng TJ. Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Apr 21; 16(2):78-80. PubMed ID: 7540115 [Abstract] [Full Text] [Related] Page: [Next] [New Search]